CAMDEN NATIONAL CORP CAC
Nasdaq · XNAS · stock · National Commercial Banks
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
43.7%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $41.7M | $65.2M | — | $58.2M | $696.6M |
| 2024 | $35.7M | $53.0M | — | $55.4M | $531.2M |
| 2023 | $33.6M | $43.4M | — | $64.9M | $495.1M |
| 2022 | $33.3M | $61.4M | — | $103.0M | $451.3M |
| 2021 | $32.0M | $69.0M | — | $140.9M | $541.3M |
| 2020 | $27.7M | $59.5M | — | $15.3M | $529.3M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000750686 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.